UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033182 |
|---|---|
| Receipt number | R000037839 |
| Scientific Title | A multicenter phase II study of Nivolumab monotherapy in recurrent and/or metastatic gastrointestinal cancer patients with high Tumor Mutation Burden (TMB-H) |
| Date of disclosure of the study information | 2018/08/10 |
| Last modified on | 2023/07/03 09:54:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/06/28 16:32:36 | ||
| 2 | Update | 2018/09/19 08:35:07 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2018/11/29 17:26:27 | Institutions |
|
| 4 | Update | 2019/08/01 14:23:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 5 | Update | 2021/07/30 11:33:20 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2022/06/21 10:43:56 | Recruitment status Date of IRB Last follow-up date |
|
| 7 | Update | 2023/01/04 08:40:51 | Number of participants that the trial has enrolled |
|
| 8 | Update | 2023/07/03 09:54:56 | Last follow-up date |
